Centiva Capital’s Replimune Group REPL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$138K Hold
18,000
﹤0.01% 1345
2025
Q4
$175K Buy
+18,000
New +$153K ﹤0.01% 1009
2025
Q3
Sell
-74,253
Closed -$474K 1723
2025
Q2
$690K Buy
+74,253
New +$648K 0.01% 799
2024
Q3
Sell
-11,134
Closed -$100K 2523
2024
Q2
$100K Buy
+11,134
New +$77.6K ﹤0.01% 1854

Other funds holding REPL

Centiva Capital's REPL Position: Q1 2026 in Review

Centiva Capital held its Replimune Group (REPL) position steady in Q1 2026 at 18,000 shares worth $138K. The position accounts for ﹤0.01% of the portfolio, ranked #1345.

Centiva Capital first reported a position in REPL in Q2 2024 and has held it in 4 quarters since. The position peaked at $690K in Q2 2025. 180 funds tracked by Wall St. Rank hold REPL as of Q1 2026.

  • Centiva Capital held 18,000 shares of Replimune Group worth $138K as of Q1 2026.
  • Centiva Capital left its Replimune Group share count unchanged in Q1 2026.
  • Replimune Group made up ﹤0.01% of Centiva Capital's portfolio in Q1 2026, its #1345 holding.
  • Centiva Capital first reported a position in Replimune Group in Q2 2024 and has held it in 4 quarters since.
  • Centiva Capital's Replimune Group position peaked at $690K in Q2 2025.
  • 180 funds tracked by Wall St. Rank held Replimune Group as of Q1 2026.

Based on Centiva Capital's 13F filing for Q1 2026, filed 14 May 2026.